Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Various Bacterial Secondary Metabolites and Their Roles in Basic Metabolic Processes
Industrial Applications of Microbial Secondary Metabolites A Modern Approach
1 January 2026
Lodhi J.
Genotype 4 hepatitis C virus-a review of a diverse genotype
Advances in Medical Sciences
March 2023
Brzdęk M.
Establishing a research production line in real-life settings: the case of Hepatitis C management in a viral hepatitis specialized Egyptian center
Current Medical Research and Opinion
2022
El Kassas M.
Direct-acting antiviral regimens in Egyptian patients with chronic hepatitis C virus infection: A real-world single-center experience
Arab Journal of Gastroenterology
December 2021
Naguib G.G.
ENNAVIA is a novel method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides
Briefings in Bioinformatics
1 November 2021
Timmons P.B.
Open Access
The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting
Virusdisease
September 2021
Naguib G.G.
All Open Access, Green
Serum MicroRNAs as predictors for fibrosis progression and response to direct-acting antivirals treatment in hepatitis C virus genotype-4 Egyptian patients
International Journal of Clinical Practice
April 2021
Khairy R.M.M.
Open Access
Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt
Expert Review of Anti Infective Therapy
2 July 2020
Esmat G.
Antiviral peptides as promising therapeutic drugs
Cellular and Molecular Life Sciences
1 September 2019
Vilas Boas L.C.P.
Open Access
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
World Journal of Gastroenterology
14 October 2018
Omran D.
Open Access
Characterization of demographics and NS5A genetic diversity for hepatitis C virus genotype 4-infected patients with or without cirrhosis treated with ombitasvir/paritaprevir/ritonavir
Journal of Viral Hepatitis
September 2018
Schnell G.
Open Access
HCV in Egypt, prevention, treatment and key barriers to elimination
Expert Review of Anti Infective Therapy
3 April 2018
El Kassas M.
Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens
Journal of Interferon and Cytokine Research
March 2018
El-Raziky M.
Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt's hepatocellular cancer epidemic: Simulation of alternatives
BMJ Global Health
March 2018
Ma W.
Open Access
Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt
Plos One
October 2017
Nagaty A.
Open Access
Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patients
Journal of Infection in Developing Countries
October 2017
Kamel A.M.
Open Access
Comparison of rapid virological response in patient on treatment with Direct acting antivirals (DAA) (sofosbuvir) verses DAA along with pegylated interferon for chronic hepatitis C virus infection genotype 3
Pakistan Journal of Medical and Health Sciences
July-September 2017
Noor F.
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
Journal of Viral Hepatitis
1 April 2017
El-Akel W.
Management of hepatitis C genotype 4 in the directly acting antivirals era
BMJ Open Gastroenterology
31 December 2016
Hathorn E.
Open Access
Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4
Clinical Interventions in Aging
4 May 2016
Gabr S.A.
Open Access
Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy
Journal of Interferon and Cytokine Research
March 2016
Esmat G.E.
The effect of the degree of hepatitis C-related fibrosis on the responsiveness to pegylated interferon α-2a versus pegylated interferon α-2b: Egyptian study
Egyptian Liver Journal
2016
El Shazly Y.M.
Bcl-2 and p53 expression in hepatic tissues of Egyptian patients with Chronic Hepatitis C
Journal of the Pakistan Medical Association
November 2015
Allam A.
Efficacy and tolerability of peginterferon alpha-2a and peginterferon alpha-2b in Iranian patients with chronic hepatitis C
Hepatitis Monthly
29 September 2015
Pouresmaeeli M.
Open Access